Oxidative stress and vascular damage in hypertension

Current Hypertension Reports

Volumn 2, Issue 1, 2000, Pages 98-105

  Touyz, Rhian M ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; FREE RADICAL; SUPEROXIDE DISMUTASE;

HUMAN; HYPERTENSION; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; REVIEW; VASCULAR ENDOTHELIUM;

ANGIOTENSIN II; ENDOTHELIUM, VASCULAR; FREE RADICALS; HUMANS; HYPERTENSION; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

EID: 0034137152     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-000-0066-3     Document Type: Article

References (52)

1. Cosentino F, Sill JC, Katusic ZS: Role of superoxide anions in the mediation of endothelium-dependent contractions. Hypertension 1994, 23:229-235.
2. Touyz RM, Schiffrin EL: Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells. Hypertension 1999, 34(Part 2):976-982.
3. Zafari AM, Ushio-Fukai M, Akers M, et al.: Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. Hypertension 1998, 32:488-495.
4. Rao GN, Berk BC: Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 1992, 70:593-599.
5. Harrison DG: Cellular and molecular mechanisms of endo-thelial cell dysfunction. J Clin Invest 1997, 2153-2157.
6. Chin JH, Azhar S, Hoffman BB: Inactivation of endothelium-derived relaxing factor by oxidized lipoproteins. J Clin Invest 1992, 89:10-1 8.
7. Wei EP, Kontos HA, Christman CW: Superoxide generation and reversal of acetylcholine-induced cerebral arteriolar dilation after acute hypertension. Circ Res 1985, 57:781-787.
8. Laursen JB, Rajagopalan S, Galis Z, et al.: Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 1997, 95:588-593.
9. Kerr S, Brosnan J, McIntyre M: Superoxide anion production is increased in a model of genetic hypertension. Role of endothelium. Hypertension 1999, 33:1353-1358.
10. Wang D, Hope S, Du Y, et al.: Paracrine role of adventitial superoxide anion in mediating spontaneous tone of the isolated rat aorta in angiotensin II-induced hypertension. Hypertension 1999, 33:1225-1232.
11. Schnackenberg CG, Welch W, Wilcox CS: Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic. Role of nitric oxide. Hypertension 1999, 32:59-64.
12. Chappel LC, Seed PT, Briley AL, et al.: Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomized trial. Lancet 1999, 354:810-81 6.
13. Sharma RC, Hodis HN, Mack WJ, et al.: Probucol suppresses oxidant stress in hypertensive arteries. Immunohistochemi-cal evidence. Am J Hypertens 1996, 9:577-590.
14. Fridovich I: Superoxide anion radical, superoxide dismutases, and related matters. J Biol Chem 1997, 272:18515-18517.
15. Darley-Usmar V, Wiseman H, Halliwell B: Nitric oxide and oxygen radicals; a question of balance. FEBS Lett 1995, 369:131-135.
16. Abe J-I, Berk BC: Reactive oxygen species of signal trans-duction in cardiovascular disease. Trends Cardiovasc Med 1998, 8:59-64.
17. Puig JG, Ruilope LM: Uric acid as a cardiovascular risk factor in arterial hypertension. J Hypertens 1999, 17:869-872.
18. Griendling KK, Ushio-Fukai M: NADH/NADPH oxidase and vascular function. Trends Cardiovasc Med 1997, 301-307.
19. Rajagopalan S, Kurz S, Munzel T: Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest 1996, 97:1916-1923.
20. De Leo FR, Ulman KV, Davis AR, et al.: Assembly of the human neutrophil NADPH oxidase involves binding of p67phox and flavocytochrome b to a common functional domain in p47phox. J Biol Chem 1996, 271:17013-17020.
21. Jones SA, O'Donnell VB, Wood JD: Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol 1996, 271:H1626-H1634.
22. Azumimi H, Inoue N, Takeshita S, et al.: Expression of NADH/NADPH oxidase p22phox in human coronary arteries. Circulation 1999, 100:1494-1498.
23. Marumo T, Schini-Kerth VB, Brandes RP, Busse R: Glucocor-ticoids inhibit superoxide anion production and p22phox mRNA expression in human aortic smooth muscle cells. Hypertension 1999, 32:1083-1088.
24. Suh YA, Arnold RS, Lassegue B, et al.: Cell transformation by the superoxide-generating oxidase Mox1. Nature 1999, 410:79-82.
25. McIntyre M, Bohr DF, Dominiczak AF: Endothelial function in hypertension. The role of superoxide anion. Hypertension 1999, 34:539-545.
26. De Keulener GW, Alexander RW, Ushio-Fukai M: Tumour necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle. Biochem J 1998, 329:653-657.
27. Sundaresan M, Yu ZX, Ferrans VJ, et al.: Requirement for generation of H2O2 for PDGF signal transduction. Science 1995, 270:296-299.
28. Finkel T: Oxygen radicals and signaling. Curr Opin Cell Biol 1998, 10:248-253.
29. Ushio-Fukai M, Zafari AM, Fukui T, et al.: p22phox is a critical component of the superoxide of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 1996, 271:23317-23321.
30. Tsai MH, Yu CL, Stacey DW: A cytoplasmic protein inhibits the GTPase activity of H-Ras in a phospholipid-dependent manner. Science 1990, 250:982-985.
31. Brown MR, Miller FJ, Li W-G, et al.: Overexpression of human catalase inhibits proliferation and promotes apoptosis in vascular smooth muscle cells. Circ Res 1999, 85:524-533.
32. Griendling KK, Harrison DG: Dual role of reactive oxygen species in vascular growth. Circ Res 1999, 85:562-563.
33. Rajagopalan S, Meng XP, Ramasamy S, et al.: Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. J Clin Invest 1996, 98:2572-2579.
34. Hu Q, Corda S, Zweier JL, et al.: Hydrogen peroxide induces intracellular calcium oscillations in human aortic endo-thelial cells. Circulation 1998, 97:268-275.
35. Sabri A, Byron KL, Samarel AM, et al.: Hydrogen peroxide activates MAP kinases and Na+/H+ exchange in neonatal rat cardiomyocytes. Circ Res 1998, 82:1053-1062.
36. Somers MJ, Harrison DG: Reactive oxygen species and the control of vasomotor tone. Current Hypertension Reports 1999, 1:102-108.
37. Fukui T, Ishizaka N, Rajagopalan S: p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res 1997, 80:45-51.
38. Fukai T, Siegfried MR, Ushio-Fukai M, et al.: Modulation of extracellular superoxide dismutase expression by angio-tensin II and hypertension. Circ Res 1999, 85:23-28.
39. Suzuki H, De Lano FA, Parks DA, et al.: Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc Natl Acad Sci USA 1998, 95:4754-4759.
40. White BH, Sidhu A: Increased oxidative stress in renal proximal tubules of the SHR: a mechanism for defective dopamine D1A receptor/G - protein coupling. J Hypertens 1998, 16:1659-1665.
41. Negishi H, Ikeda K, Sagara M, Sawamura Y: Increased oxidative DNA damage in stroke-prone SHR. Clin Exp Pharmacol Physiol 1999, 26:482-484.
42. Singh RB, Niaz MA, Rastogi SS, et al.: Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. J Hum Hypertens 1999, 13:203-208.
43. Koska J, Syrova D, Blazicek P, et al.: Malondialdehyde, lipo-fuscin and activity of antioxidant enzymes during physical exercise in patients with essential hypertension. J Hypertens 1999, 17:529-535.
44. Akpaffiong MJ, Taylor AA: Antihypertensive and vasodilator actions of antioxidants in SHR. Am J Hypertens 1998, 11:1 450-1460.
45. Nunes GL, Sgoutas DS, Redden RA: Combination of vitamins C and E alters the response to coronary balloon injury in the pig. Arterioscler Thromb Vasc Biol 1995, 15:156-165.
46. Nakazono K, Watanabe N, Matsuno S, et al.: Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci USA 1991, 88:10045-10048.
47. Tschudi M, Mesaros S, Luscher TF, Malinski T: Direct in situ measurement of nitric oxide in mesenteric resistance arteries: increased decomposition by superoxide in hypertension. Hypertension 1996, 27:32-35.
48. Kurose I, Wolf R, Cerwinka W, Granger DN: Microvascular responss to ischemia/reperfusion in normotensive and hypertensive rats. Hypertension 1999, 34:212-216.
49. Kristal B, Shurtz-Swirrski R, Chezar J, et al.: Participation of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation in patients with essential hypertension. Am J Hypertens 1998, 11:921-928.
50. Alexander RW: Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 1995, 25:155-161.
51. Aminbakhsh A, Mancini G B J: Chronic antioxidant use and changes in endothelial dysfunction: a review of clinical investigations. Can J Cardiol 1999, 15:895-903.
52. Parik T, Alliikmmets K, Teesalu R, Zilmer M: Evidence for oxidative stress in essential hypertension: perspective for antioxidant therapy. J Cardiovasc Risk 1996, 3:49-54.